Marker X 銳準生醫 Alternatives & Competitors

12 companies similar to Marker X 銳準生醫 — Faster, more precise, and well in advance: Advocating preventative medicine towa...

PrognomiQ Inc

Transform healthcare and early disease detection through the power of multi-omics data.

44 $145.00M

San Mateo, United States

Biopharma Biotechnology +2

Geneoscopy

Cancer Prevention | Diagnostics | Precision Medicine

60 Series B $112.90M

St. Louis, United States

Biotechnology Health Care

Biodesix, Inc.

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Aw...

356 Post-IPO Equity $312.49M

Louisville, United States

Biotechnology Health Care

Previse

Previse is on a mission to save lives through the prediction and earlier detection of canc...

13 Grant $6.25M

Baltimore, United States

Biotechnology Medical Devices

Rival Readout

Competing with Marker X 銳準生醫? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

FuturNet Communication

La vision du futur

1 Venture round $3.90M

Nottingham, United Kingdo...

Biopharma Biotechnology

Cleveland Diagnostics

Cleveland Diagnostics is a cancer biotechnology company that is changing the shape of canc...

76 Private Equity $110.98M

Cleveland, United States

Biotechnology Health Care

Avenna Ltd

Biotech Startup specialised in development of practical, precision healthcare solutions fo...

United Kingdom

Biotechnology Health Care +1

Theramir Ltd

Developing novel microRNA based therapeutics and companion diagnostics for patients and he...

Limassol, Cyprus

Biopharma Biotechnology +1

SAGA Diagnostics

Redefining the early detection of molecular residual disease (MRD).

97 Series A $15.25M

Morrisville, United State...

Biotechnology

Myriad Genetics

Leading molecular diagnostic testing & precision medicine company dedicated to advancing h...

2902 IPO $315.00M

Salt Lake City, United St...

Biotechnology

Beacon Biomedical

Easy, Accurate & Affordable Blood Based Screening for early detection of cancer and COVID-...

1 Acquired $20.63M

Phoenix, United States

Biotechnology Health Care

Nano4 Global

Fast and affordable colorimetric precision nanodiagnostics

2 Seed $50.00K

Portugal

Biotechnology Health Care +2

About Marker X 銳準生醫

Marker Exploration Corporation (Marker X) is a biotech startup founded in 2020 with a focus on discovering novel disease biomarkers. Their slogan "Discovering Tomorrow's Health, Today: Precision Screening for Early Cancer Detection and Chronic Disease Management" epitomizes their mission. Using advanced mass spectromet...

Business keywords

Biotech Company, Cancer Detection, Precision Medicine, Early Screening, Disease Biomarkers, Mass Spectrometry, Proteomic Methods, Companion Diagnostics, Chronic Disease Management, Early Intervention

Frequently Asked Questions

Companies similar to Marker X 銳準生醫 include PrognomiQ Inc, Geneoscopy, Biodesix, Inc., Previse, FuturNet Communication. They work in Biotechnology and share Marker X 銳準生醫's focus on precision medicine, companion diagnostics and cancer detection.

Bounce Watch lists 12 companies that share Marker X 銳準生醫's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Marker X 銳準生醫: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Marker X 銳準生醫 Profile PrognomiQ Inc Alternatives Geneoscopy Alternatives Biodesix, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Marker X 銳準生醫 on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.